No abstract available
MeSH terms
-
Anti-Arrhythmia Agents / adverse effects
-
Anti-Arrhythmia Agents / therapeutic use
-
Atrial Fibrillation / mortality
-
Atrial Fibrillation / surgery*
-
Cardiomyopathies / mortality
-
Cardiomyopathies / prevention & control
-
Catheter Ablation*
-
Humans
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Recurrence
-
Survival Rate
-
Thromboembolism / mortality
-
Thromboembolism / prevention & control
-
Treatment Failure